Infectious Diseases in Obstetrics and Gynecology / 2009 / Article / Tab 1

Clinical Study

Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes

Table 1

Demographics ITT Population.

DemographicsVAL-PlaceboPlacebo-VAL

No. of subjects3535
Female gender, (%)22 (63)27 (77)
Mean Age, years (SD), range29 (9), 18–4933 (10), 20–58
White, (%)19 (54)17 (49)
Black, (%)13 (37)15 (43)
HSV-1a and HSV-2 Antibody Positive, (%)17 (49)19 (54)
HSV-1 Antibody Positive, HSV-2 Antibody Negative, (%)2 (6)1 (3)
HSV-1 Antibody Negative, HSV-2 Antibody Positive, (%)13 (37)12 (34)
HSV-1 and HSV-2 Antibody Negative, (%)3 (9)3 (9)

aOne patient in each treatment group had an HSV-1 equivocal result and are included here.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.